Clinical intervention studies with black cohosh for treatment of acute menopausal symptoms Study Subjects Intervention Daiber (24) 36 German women with Uncontrolled trial, climacteric symptoms, 45-62 parallel: Remifemin
twice/ years day Vorberg (25) 50 German women with Uncontrolled trial, climacteric symptoms, 45-60 parallel: Remifemin
40 years drops twice/day (liquid extract).
Not to be outdone, GlaxoSmithKline has launched RemiFemin
Menopause, billed as a uniquely formulated supplement that has been clinically shown to reduce menopause symptoms.
The usual dosage of Remifemin
is one tablet twice daily.
Evidence: In the best study on black cohosh root, 30 women who took Remifemin
for 12 weeks reported far fewer hot flashes and other symptoms than 20 similar women who were given a placebo.
The thirteen plant extracts and the Remifemin
[TM] and CimiPure [R] extracts were analyzed by HPLC using a method described previously (Struck et al.
For example, the introduction of Remifemin
for menopause, Citrucel tablets for fiber therapy and Calcium for Life for bone health are all examples of products targeted primarily to women as they age," he explains.
Maker of Remifemin
, leading European menopausal remedy.
Pockaj said that a smaller pilot trial that she conducted previously showed positive results when she used Remifemin
but she was unable to obtain this product from its manufacturer for the larger trial now being reported.
Researchers looked for correlations between dietary supplement usage and the incidence of breast cancer, comparing a range of products including any phytoestrogen and any isoflavone, including genistein, red clover, soy medications, black cohosh or Remifemin
, Biestrogen, DHEA, Dong quai, Estrovin, ginseng, Promensil, Rejuvex, steroid creams, and yam creams.
In fact, the Physical & Mental Wellness category joined the Top 10 list for the second consecutive month driven by continued growth in sales of Remifemin
, an estrogen-free herbal supplement containing black cohosh, Healthy Woman soy menopause supplement, and Nature's Resource Soy Balance.
8%, showing that women given Remifemin
respond better than if they were assigned to tibolone in terms of efficacy-risk balance.
In addition to examining the product's lack of estrogenic effect, the study compared the effectiveness and safety of two dosage forms of RemiFemin